CHF 6532

· Chiesi Farmaceutici S.p.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CHF 6532, covering 2022-04-08 to 2022-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of CHF 6532 in Patients With Uncontrolled Severe Eosinophilic Asthma [Phase 3]